> Knight Therapeutics and SIFI S.p.A. Announce Filing of New Drug Submission for NETILDEXTM in CanadaTM
"The only thing worse than being blind is having sight but no vision."
Helen Keller

 
 
L'Oculista Italiano is an Ophthalmology journal, founded in 1968, publishing scientific articles, reviews and interviews with the aim to contribute to scientific and professional update of...
 
Find news and information about SIFI global and local activities and vision science related events around the world.
 
SIFI Company Vision Video SIFI Press Conference "Integrated innovations to support the visually impaired" SIFI Diary from ESCRS 2015 with ¡Hasta la Vista SIFI!...

On our Social Channels

From our News Center

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian Eye Care company, today...
 

 

20 September

As of today Fabrizio Folco assumes management of the company's organization for the Italian market SIFI, Italian leader in the development and marketing of innovative...
Follow Us!